Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Novel Risk Factors for Type 2 Diabetes
Read More
FDA Approvals
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Read More
Ninety Years of Insulin: What’s Needed? What’s New?
Read More
FDA Approvals
The Ancient Anti-Inflammatory Drug Salsalate Lowers Blood Glucose Levels
Read More
Head-to-Head Comparison: Early Insulin Glargine Can Help Achieve Glycemic Target in Type 2 Diabetes
Read More
The Diabetes Epidemic Is Like a Tsunami Hitting in Waves
Read More
FDA Approvals
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Read More
FDA Approvals
Novel Basal Insulin LY2605541 Lowers Blood Glucose, Enhances Weight Loss
Read More
FDA Approvals
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Read More
Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management
Read More
192
193
194
195
196
197
198
Page 195 of 244
Results 1941 - 1950 of 2436
